Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience.

Hapgood G, Pickles T, Sehn LH, Villa D, Klasa R, Scott DW, Gerrie AS, Gascoyne RD, Slack GW, Parsons C, Morris JW, Connors JM, Savage KJ.

Br J Haematol. 2017 Jan;176(2):234-240. doi: 10.1111/bjh.14404. Epub 2016 Oct 21.

PMID:
27766622
2.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

PMID:
16236753
3.

Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.

Woo DK, Jones CR, Vanoli-Storz MN, Kohler S, Reddy S, Advani R, Hoppe RT, Kim YH.

Arch Dermatol. 2009 Jun;145(6):667-74. doi: 10.1001/archdermatol.2009.74.

PMID:
19528422
4.

ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.

Geller S, Canavan TN, Pulitzer M, Moskowitz AJ, Myskowski PL.

Int J Dermatol. 2018 May;57(5):515-520. doi: 10.1111/ijd.13804. Epub 2017 Oct 23. Review.

5.
6.

[Primary cutaneous anaplastic large cell lymphoma: clinical presentation, therapy and prognosis study of 10 cases].

Lü Z, Shi YK, He XH, Qin Y, Zhou SY, Zhang CG, Liu P, Yang JL.

Zhonghua Yi Xue Za Zhi. 2010 May 11;90(18):1247-50. Chinese.

PMID:
20646596
7.

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

Kridel R, Telio D, Villa D, Sehn LH, Gerrie AS, Shenkier T, Klasa R, Slack GW, Tan K, Gascoyne RD, Connors JM, Savage KJ.

Br J Haematol. 2017 Jan;176(2):210-221. doi: 10.1111/bjh.14392. Epub 2016 Oct 14.

PMID:
27739058
8.

Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.

Servitje O, Muniesa C, Benavente Y, Monsálvez V, Garcia-Muret MP, Gallardo F, Domingo-Domenech E, Lucas A, Climent F, Rodriguez-Peralto JL, Ortiz-Romero PL, Sandoval J, Pujol RM, Estrach MT.

J Am Acad Dermatol. 2013 Sep;69(3):357-65. doi: 10.1016/j.jaad.2013.04.047. Epub 2013 Jun 21.

PMID:
23796549
9.

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.

Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ.

J Clin Oncol. 2003 Nov 15;21(22):4157-64.

PMID:
14615444
10.

Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.

Shenkier TN, Voss N, Fairey R, Gascoyne RD, Hoskins P, Klasa R, Klimo P, O'Reilly SE, Sutcliffe S, Connors JM.

J Clin Oncol. 2002 Jan 1;20(1):197-204.

PMID:
11773170
11.

Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.

Campbell BA, Connors JM, Gascoyne RD, Morris WJ, Pickles T, Sehn LH.

Cancer. 2012 Sep 1;118(17):4156-65. doi: 10.1002/cncr.26687. Epub 2012 Jan 17.

12.

Treatment results of tonsillar lymphoma: a 10-year experience.

Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.

Ann Hematol. 2005 Apr;84(4):223-6. Epub 2004 Mar 23.

PMID:
15042316
13.

Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.

Gratzinger D, Million L, Kim YH.

Am J Dermatopathol. 2015 Oct;37(10):767-70. doi: 10.1097/DAD.0000000000000377.

PMID:
26381026
14.

Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.

Kempf W, Kazakov DV, Paredes BE, Laeng HR, Palmedo G, Kutzner H.

Dermatology. 2013;227(4):346-52. doi: 10.1159/000355479. Epub 2013 Nov 12.

15.

Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.

Cornejo CM, Novoa RA, Krisch RE, Kim EJ.

Cutis. 2016 Oct;98(4):253-256.

PMID:
27874877
16.

Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Rodriguez MA, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas F.

J Clin Oncol. 2001 Jan 15;19(2):398-405.

PMID:
11208831
17.
18.

Treatment and outcomes of primary breast lymphoma.

Caon J, Wai ES, Hart J, Alexander C, Truong PT, Sehn LH, Connors JM.

Clin Breast Cancer. 2012 Dec;12(6):412-9. doi: 10.1016/j.clbc.2012.07.006. Epub 2012 Sep 25.

PMID:
23018097
19.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
20.

Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.

King MT, Donaldson SS, Link MP, Natkunam Y, Advani RH, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):67-75. doi: 10.1016/j.ijrobp.2015.02.001.

PMID:
25863755

Supplemental Content

Support Center